NS

Narendra Singh Jaswant Mali

Active Director Director DIN 09853849
DIN 09853849 First appointment Jan 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Narendra Singh Jaswant Mali

Data last updated:

Narendra Singh Jaswant Mali is a Director at Rnn Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 09853849
Primary Designation Director
Industry Pharma
First Appointment 06 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rnn Pharmaceutical Private Limited U24100MH2023PTC397073
Director06 Jan 20232023Active

Board colleagues of Narendra Singh Jaswant Mali

Directorship timeline

Open interactive timeline →
Rnn Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Narendra Singh Jaswant Mali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narendra Singh Jaswant Mali

Narendra Singh Jaswant Mali currently holds 1 directorship: Rnn Pharmaceutical Private Limited (Director, since 06 Jan 2023).

Narendra Singh Jaswant Mali was first appointed on 06 Jan 2023 as Director at Rnn Pharmaceutical Private Limited.

The current boards of Narendra Singh Jaswant Mali's companies include Narendra Naurangbahadur Yadav (Rnn Pharmaceutical Private Limited), Ram Krishan Dubey (Rnn Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available